Snapshot · S&P 1500 · generated 2026-09-02 21:22 UTC

SRPT — Sarepta Therapeutics, Inc.

EXPENSIVE (MOS -599.1%) · Quality 47/100

SRPT - Sarepta Therapeutics, Inc.
Data generated 2026-09-02 21:22 UTC (nightly scan, universe: S&P 1500).
Price: 23.21 USD
Intrinsic value: 3.32 USD
Margin of safety: -599.1%
Implied growth (reverse DCF): +25.2% (model assumes +0.0%)
Valuation: EXPENSIVE
Value Score: 0.7
Quality: 47/100
Moat score: 0 (erosion: none)
EXPENSIVE (MOS -599.1%) - Quality 47/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/SRPT
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

23.21

Intrinsic value

3.32

Margin of safety

-599.1%

Implied growth (reverse DCF)

+25.2%

model assumes +0.0%

Value Score

0.7

Quality

Psychology

-77.8

Discovery

33.7

price/volume attention only

Moat score

erosion: none

Value Score: bottom 1% of S&P 1500 · Quality: bottom 16%

Open the interactive Deep Dive for SRPT →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/SRPT - see the API docs for the full read-only surface, including an MCP server for AI assistants.